Company Intelligence
Nabla Bio
Nabla Bio provides enterprise-grade artificial intelligence solutions, delivering specialized We use AI to design antibodies for intractable diseases technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Boston, United States
- Website
- www.nabla.bio
- Founded
- 2020
- Employees
- 8
- Stage
- Growth
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Nabla Bio is a Healthcare AI company based in Boston, United States, founded in 2020.
Nabla Bio develops we use AI to design antibodies for intractable diseases.
What it builds
We use AI to design antibodies for intractable diseases
Why It Matters
Nabla Bio provides enterprise-grade artificial intelligence solutions, delivering specialized We use AI to design antibodies for intractable diseases technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Nabla Bio
Explore Nabla Bio by Nabla Bio. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Nabla Bio
Industry
Products
Capabilities
- We use AI to design antibodies for intractable diseases
Features
- We use AI to design antibodies for intractable diseases
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Nabla Bio do?
Nabla Bio specializes in artificial intelligence, developing We use AI to design antibodies for intractable diseases to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Nabla Bio based and when was it founded?
Nabla Bio is based in United States and was founded in 2020.
What are the main products offered by Nabla Bio?
The flagship platform from Nabla Bio is We use AI to design antibodies for intractable diseases, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Nabla Bio?
Nabla Bio primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.